Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy

被引:128
作者
Purohit, Treta [1 ,2 ]
Cappell, Mitchell S. [1 ,2 ]
机构
[1] William Beaumont Hosp, Div Gastroenterol & Hepatol, MOB 602,3535 W Thirteen Mile Rd, Royal Oak, MI 48073 USA
[2] Oakland Univ, William Beaumont Sch Med, Royal Oak, MI 48073 USA
关键词
Primary biliary cirrhosis; Ursodeoxycholic acid; Cirrhosis; Liver transplantation; Cholestatic liver disease;
D O I
10.4254/wjh.v7.i7.926
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Primary biliary cirrhosis (PBC) is an autoimmune, slowly progressive, cholestatic, liver disease characterized by a triad of chronic cholestasis, circulating anti-mitochondrial antibodies (AMA), and characteristic liver biopsy findings of nonsuppurative destructive cholangitis and interlobular bile duct destruction. About 10% of PBC patients, however, lack AMA. A variant, called PBC-autoimmune hepatitis (AIH) overlap, is characterized by the above findings of PBC together with findings of elevated serum alanine aminotransferase, elevated serum immunoglobulin G, and circulating anti-smooth muscle antibodies, with liver biopsy demonstrating periportal or periseptal, lymphocytic, piecemeal necrosis. PBC is hypothesized to be related to environmental exposure in genetically vulnerable individuals. It typically occurs in middle-aged females. Prominent clinical features include fatigue, pruritis, jaundice, xanthomas, osteoporosis, and dyslipidemia. The Mayo Risk score is the most widely used and best prognostic system. Ursodeoxycholic acid is the primary therapy. It works partly by reducing the concentration and injury from relatively toxic bile acids. PBC-AIH overlap syndrome is treated with ursodeoxycholic acid and corticosteroids, especially budesonide. Obeticholic acid and fibrate are promising new, but incompletely tested, therapies. Liver transplantation is the definitive therapy for advanced disease, with about 70% 10-year survival after transplantation. Management of pruritis includes local skin care, dermatologist referral, avoiding potential pruritogens, cholestyramine, and possibly opioid antagonists, sertraline, or rifaximin. Management of osteoporosis includes life-style modifications, administration of calcium and vitamin D, and alendronate. Statins are relatively safe to treat the osteopenia associated with PBC. Associated Sjogren's syndrome is treated by artificial tears, cyclosporine ophthalmic emulsion to stimulate tear production; and saliva substitutes, cholinergic agents, and scrupulous oral and dental care. Complications of cirrhosis from advanced PBC include esophageal varices, ascites, spontaneous bacterial peritonitis, hepatorenal syndrome, and hepatoma formation.
引用
收藏
页码:926 / 941
页数:16
相关论文
共 222 条
[1]
Fatigue in primary biliary cirrhosis [J].
Abbas, Ghulam ;
Jorgensen, Roberta A. ;
Lindor, Keith D. .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2010, 7 (06) :313-319
[2]
Pharmacological treatment of biliary cirrhosis with ursodeoxycholic acid [J].
Abbas, Ghulam ;
Lindor, Keith D. .
EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (03) :387-392
[3]
Liver transplantation in precirrhotic biliary tract disease: Portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy [J].
Abraham, Susan C. ;
Kamath, Patrick S. ;
Eghtesad, Bijan ;
Demetris, Anthony J. ;
Krasinskas, Alyssa M. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2006, 30 (11) :1454-1461
[4]
Addison T, 1851, GUYS HOSP REP, V7, P265
[5]
A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis [J].
Agmon-Levin, Nancy ;
Shapira, Yinon ;
Selmi, Carlo ;
Barzilai, Ori ;
Ram, Maya ;
Szyper-Kravitz, Martine ;
Sella, Sara ;
Katz, Bat-sheva Porat ;
Youinou, Pierre ;
Renaudineau, Yves ;
Larida, Bruno ;
Invernizzi, Pietro ;
Gershwin, M. Eric ;
Shoenfeld, Yehuda .
JOURNAL OF AUTOIMMUNITY, 2010, 34 (01) :55-58
[6]
Neuroactive steroids and fatigue severity in patients with primary biliary cirrhosis and hepatitis C [J].
Ahboucha, S. ;
Butterworth, R. F. ;
Pomier-Layrargues, G. ;
Vincent, C. ;
Hassoun, Z. ;
Baker, G. B. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2008, 20 (06) :671-679
[7]
PRIMARY BILIARY CIRRHOSIS [J].
AHRENS, EH ;
PAYNE, MA ;
KUNKEL, HG ;
EISENMENGER, WJ ;
BLONDHEIM, SH .
MEDICINE, 1950, 29 (04) :299-364
[8]
The Specificity of Fatigue in Primary Biliary Cirrhosis: Evaluation of a Large Clinic Practice [J].
Al-Harthy, Nadya ;
Kumagi, Teru ;
Coltescu, Catalina ;
Hirschfield, Gideon M. .
HEPATOLOGY, 2010, 52 (02) :562-570
[9]
Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis [J].
Allocca, M. ;
Crosignani, A. ;
Gritti, A. ;
Ghilardi, G. ;
Gobatti, D. ;
Caruso, D. ;
Zuin, M. ;
Podda, M. ;
Battezzati, P. M. .
GUT, 2006, 55 (12) :1795-1800
[10]
Risk of adverse events with fibrates [J].
Alsheikh-Ali, AA ;
Kuvin, JT ;
Karas, RH .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (07) :935-+